{"title":"门诊病人肠外抗菌疗法......及其他研究","authors":"Tom Nolan","doi":"10.1136/bmj.q2558","DOIUrl":null,"url":null,"abstract":"Tom Nolan reviews this week’s research When it comes to peripherally inserted lines for outpatient parenteral antimicrobial therapy (OPAT), where should one draw the line? Midline catheters, which end in peripheral veins, are thought to offer lower risks of infection and thromboembolism than peripherally inserted central catheters (PICCs). A new cohort study supports this, finding that, for a device dwell of 14 days or less, midline catheters were associated with a lower risk of major complications (0.9% v 5.3%, adjusted hazard ratio 0.29 (95% CI 0.12 to 0.68)). However, the study design means that confounding by indication—whereby lower risk patients received a midline catheter—is hard to measure and exclude. JAMA Intern Med doi:10.1001/jamainternmed.2024.5984 Don’t wait until after prostate cancer diagnosis to consider life expectancy, advises an editorial …","PeriodicalId":22388,"journal":{"name":"The BMJ","volume":"19 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Outpatient parenteral antimicrobial therapy … and other research\",\"authors\":\"Tom Nolan\",\"doi\":\"10.1136/bmj.q2558\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Tom Nolan reviews this week’s research When it comes to peripherally inserted lines for outpatient parenteral antimicrobial therapy (OPAT), where should one draw the line? Midline catheters, which end in peripheral veins, are thought to offer lower risks of infection and thromboembolism than peripherally inserted central catheters (PICCs). A new cohort study supports this, finding that, for a device dwell of 14 days or less, midline catheters were associated with a lower risk of major complications (0.9% v 5.3%, adjusted hazard ratio 0.29 (95% CI 0.12 to 0.68)). However, the study design means that confounding by indication—whereby lower risk patients received a midline catheter—is hard to measure and exclude. JAMA Intern Med doi:10.1001/jamainternmed.2024.5984 Don’t wait until after prostate cancer diagnosis to consider life expectancy, advises an editorial …\",\"PeriodicalId\":22388,\"journal\":{\"name\":\"The BMJ\",\"volume\":\"19 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The BMJ\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/bmj.q2558\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The BMJ","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmj.q2558","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
汤姆-诺兰(Tom Nolan)回顾本周研究 当谈到用于门诊肠外抗菌治疗(OPAT)的外周插入管路时,应该在哪里划线?与外周置入中心静脉导管(PICC)相比,末端位于外周静脉的中线导管被认为具有更低的感染和血栓栓塞风险。一项新的队列研究证实了这一点,该研究发现,在设备停留时间为 14 天或更短的情况下,中线导管发生重大并发症的风险较低(0.9% 对 5.3%,调整后危险比为 0.29(95% CI 0.12 至 0.68))。然而,研究设计意味着很难测量和排除适应症的混杂因素,即风险较低的患者接受中线导管。JAMA Intern Med doi:10.1001/jamainternmed.2024.5984 社论建议,不要等到前列腺癌确诊后才考虑预期寿命 ...
Outpatient parenteral antimicrobial therapy … and other research
Tom Nolan reviews this week’s research When it comes to peripherally inserted lines for outpatient parenteral antimicrobial therapy (OPAT), where should one draw the line? Midline catheters, which end in peripheral veins, are thought to offer lower risks of infection and thromboembolism than peripherally inserted central catheters (PICCs). A new cohort study supports this, finding that, for a device dwell of 14 days or less, midline catheters were associated with a lower risk of major complications (0.9% v 5.3%, adjusted hazard ratio 0.29 (95% CI 0.12 to 0.68)). However, the study design means that confounding by indication—whereby lower risk patients received a midline catheter—is hard to measure and exclude. JAMA Intern Med doi:10.1001/jamainternmed.2024.5984 Don’t wait until after prostate cancer diagnosis to consider life expectancy, advises an editorial …